|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―May―10 |
Correspondence on COVID-19 Vaccination and Acquired Haemophila A |
Pathum Sookaromdee, Viroj Wiwanitkit |
2 |
[GO] |
2022―Apr―05 |
Haemostatic Disarray Following COVID-19 Vaccine - a Case of Acquired Haemophila A |
Evelyn O'Shea, Orna Daly, Cleona Duggan, Maeve Crowley |
3 |
[GO] |
2022―Apr―01 |
Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection |
Falmata Laouan Brem, Miri Chaymae, Hammam Rasras, Manal Merbouh, Mohammed-Amine Bouazzaoui, Houssam Bkiyar, et al. (+5) Naima Abda, Bazid Zakaria, Nabila Ismaili, Brahim Housni, Noha El Ouafi |
4 |
[GO] |
2022―Mar―29 |
Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients |
Indalecio Carboni Bisso, Iván Huespe, Eduardo Prado, Melina Garbarini, Marina Sol López, Luis Barrera, et al. (+3) Marcos Las Heras, Jorge Sinner, Marta Martinuzzo |
5 |
[GO] |
2022―Mar―21 |
Report of Low Incidence of Thrombosis with Early Prophylaxis in Hospitalized Patients with COVID-19 from Two Saudi Tertiary Centers |
Tarek Owaidah, Khalid Maghrabi, Feras Alfraih, Alfadil Haroon, Khawar Siddiqui, Randa Alnounou, et al. (+5) Hadeel AlOtair, Fatmah S Alqahtany, Mohannad Maghrabi, Mustafa Owaidah, Khalid AlSaleh |
6 |
[GO] |
2022―Mar―21 |
Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy? |
Felicio Savioli, Maurício Claro, Fernando Jose da Silva Ramos, Laerte Pastore |
7 |
[GO] |
2022―Mar―18 |
Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises |
Ufuk Demirci, Elif G. Umit, Hande Ozdemir, Derya Demirbag Kabayel, Ahmet Muzaffer Demir |
8 |
[GO] |
2022―Mar―11 |
Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia |
Guillaume Roberge, Marc Carrier |
9 |
[GO] |
2022―Feb―15 |
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations |
Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano, et al. (+5) Mark Ligocki, Walter Jeske, Cafer Adiguzel, Grigoris T. Gerotziafas, Jawed Fareed |
10 |
[GO] |
2022―Feb―02 |
Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination |
Mona Al-Ahmad, Mona Al Rasheed, Neveen Shalaby, Tito Rodriguez-Bouza, Lulwa Altourah |
11 |
[GO] |
2022―Jan―24 |
Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review |
Michael Joseph Cryer, Serdar Farhan, Christoph C. Kaufmann, Bernhard Jäger, Aakash Garg, Prakash Krishnan, et al. (+2) Roxana Mehran, Kurt Huber |
12 |
[GO] |
2021―Dec―22 |
Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis |
Rostami Mehrdad, Khoshnegah Zahra, Hassan Mansouritorghabeh |
13 |
[GO] |
2021―Dec―15 |
Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) |
Susan Guy, Steve Kitchen, Michael Makris, Rhona M. Maclean, Giorgia Saccullo, Joost J Vanveen |
14 |
[GO] |
2021―Dec―15 |
Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis |
Tarinee Rungjirajittranon, Weerapat Owattanapanich, Nattawut Leelakanok, Natthaporn Sasijareonrat, Bundarika Suwanawiboon, Yingyong Chinthammitr, Theera Ruchutrakool |
15 |
[GO] |
2021―Dec―15 |
Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey |
Bulent Kantarcioglu, Krishan Patel, Joseph Lewis, Omer Iqbal, Fakiha Siddiqui, Nusrat Jabeen, et al. (+3) Atul R. Laddu, Charles A. Carter, Jawed Fareed |
16 |
[GO] |
2021―Dec―15 |
Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients |
Falmata Laouan Brem, Boudouh Asmae, Yassine Amane, Mohammed-Amine Bouazzaoui, Miri Chaymae, Hammam Rasras, et al. (+7) Siham Nasri, Naima Abda, Imane Skiker, Hatim Kouismi, Bazid Zakaria, Nabila Ismaili, Noha El Ouafi |
17 |
[GO] |
2021―Dec―15 |
Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review |
Usama Waqar, Shaheer Ahmed, Syed M.H.Ali Gardezi, Muhammad Sarmad Tahir, Zain ul Abidin, Ali Hussain, et al. (+2) Natasha Ali, Syed Faisal Mahmood |
18 |
[GO] |
2021―Nov―17 |
D-dimer, COVID-19 and Diabetes: A Correspondence |
Sora Yasri, Viroj Wiwanitkit |
19 |
[GO] |
2021―Nov―17 |
Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study |
Heidi Worth, Kasey Helmlinger, Renju Raj, Eric Heidel, Ronald Lands |
20 |
[GO] |
2021―Nov―15 |
Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19 |
Priyal Agarwal, Issa Haddad |
21 |
[GO] |
2021―Nov―10 |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
Mark Klein, Vinh Dao, Fatima Khan |
22 |
[GO] |
2021―Nov―10 |
Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
23 |
[GO] |
2021―Oct―29 |
Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use |
Faruk Aydınyılmaz, Emrah Aksakal, Hilal Erken Pamukcu, Selim Aydemir, Remziye Doğan, İbrahim Saraç, et al. (+4) Sidar Şiyar Aydın, Kamuran Kalkan, Oktay Gülcü, İbrahim Halil Tanboğa |
24 |
[GO] |
2021―Oct―29 |
Low Incidence of Symptomatic Thrombotic Events in Adult Patients Hospitalized with Coronavirus 19: A Retrospective Cohort Study |
Marcelo G. Vallone, Carolina Vazquez, Fernando A. Chuliber, Verónica Privitera, Augusto Ferraris, Ramiro F. Cantarella, et al. (+4) María F. Indo, Diego M. Sanchez Thomas, Verónica A. Peuchot, Fernando J. Vazquez |
25 |
[GO] |
2021―Oct―26 |
COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis |
Muhammad Usman Hafeez, Maha Ikram, Zunaira Shafiq, Azza Sarfraz, Zouina Sarfraz, Vikash Jaiswal, et al. (+2) Muzna Sarfraz, Ivan Chérrez-Ojeda |
26 |
[GO] |
2021―Oct―25 |
Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum? |
Patrick Van Dreden, Jawed Fareed, Ismail Elalamy, Grigoris Gerotziafas |
27 |
[GO] |
2021―Oct―23 |
Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19 |
Zahra Elyaspour, Mohammad Javad Zibaeenezhad, Mahboobeh Razmkhah, Iman Razeghian-Jahromi |
28 |
[GO] |
2021―Oct―01 |
Anticoagulation for COVID-19 Patients: A Bird's-Eye View |
Firas Kreidieh, Sally Temraz |
29 |
[GO] |
2021―Sep―30 |
D-dimer Level and Diabetes in the COVID-19 Infection |
Chaymae Miri, Hajar Charii, Mohammed-Amine Bouazzaoui, Falmata Laouan Brem, Soumia boulouiz, Naima Abda, et al. (+4) Hatim Kouismi, Zakaria Bazid, Nabila Ismaili, Noha El Ouafi |
30 |
[GO] |
2021―Sep―30 |
Dengue After COVID-19 Vaccination: Possible and Might be Missed |
Amnuay Kebayoon, Viroj Wiwanitkit |
31 |
[GO] |
2021―Sep―20 |
Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination |
MA Haimei |
32 |
[GO] |
2021―Sep―09 |
Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
33 |
[GO] |
2021―Jun―30 |
Acetylsalicylic Acid and COVID-19 Prevention: A Comment |
Pathum Sookaromdee, Viroj Wiwanitkit |
34 |
[GO] |
2021―Jun―29 |
Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity |
Mehmet Gökhan Gönenli, Zeynep Komesli, Said İncir, Özlem Yalçın, Olga Meltem Akay |
35 |
[GO] |
2021―Jun―25 |
Clinical Features of COVID-19 Patients With Venous Thromboembolism |
Kai Liang, Ying Fu, Yi Kang, Huanzhang Shao, Jianxu Yang, Mingzhe Cui, Shuiting Zhai |
36 |
[GO] |
2021―Jun―18 |
Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic-Warfarin Treatment in COVID-19 |
Zeynep Yapan Emren, Oktay Şenöz, Ahmet Erseçgin, Sadık Volkan Emren |
37 |
[GO] |
2021―Jun―18 |
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19 |
Beuy Joob, Viroj Wiwanitkit |
38 |
[GO] |
2021―Jun―02 |
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination |
Bulent Kantarcioglu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, et al. (+7) Meharvan Singh, Fabio Lievano, Alfonso Tafur, Eduardo Ramacciotti, Grigoris T. Gerotziafas, Walter Jeske, Jawed Fareed |
39 |
[GO] |
2021―May―21 |
Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy |
Radu Crisan-Dabija, Alexandru Burlacu |
40 |
[GO] |
2021―May―20 |
The Meaning of D-Dimer value in Covid-19 |
Giulia Conte, Marco Cei, Isabella Evangelista, Alessandra Colombo, Josè Vitale, Antonino Mazzone, Nicola Mumoli |
41 |
[GO] |
2021―Apr―30 |
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? |
Federico Cacciapuoti, Fulvio Cacciapuoti |
42 |
[GO] |
2021―Apr―30 |
Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression |
Haoting Zhan, Haizhen Chen, Chenxi Liu, Linlin Cheng, Songxin Yan, Haolong Li, Yongzhe Li |
43 |
[GO] |
2021―Apr―28 |
Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
44 |
[GO] |
2021―Apr―20 |
Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis |
Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, Ponlapat Rojnuckarin, Noppacharn Uaprasert |
45 |
[GO] |
2021―Apr―09 |
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection |
Sandra Lopez-Castaneda, Nallely García-Larragoiti, Alan Cano-Mendez, Kenia Blancas-Ayala, Guadalupe Damian-Vázquez, Ana Itzel Perez-Medina, et al. (+3) Luis David Chora-Hernández, Carlos Arean-Martínez, Martha Eva Viveros-Sandoval |
46 |
[GO] |
2021―Apr―08 |
ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study |
Joel G. Ray, Marian J. Vermeulen, Michael J. Schull, Alison L. Park |
47 |
[GO] |
2021―Apr―05 |
Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19 |
Luis O. Bobadilla-Rosado, Santiago Mier y Teran-Ellis, Gabriel Lopez-Pena, Javier E. Anaya-Ayala, Carlos A. Hinojosa |
48 |
[GO] |
2021―Mar―31 |
Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It |
Carlos A. Cañas, Felipe Cañas, Mario Bautista-Vargas, Fabio Bonilla-Abadía |
49 |
[GO] |
2021―Mar―30 |
Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic |
Serdar Farhan, Haroon Kamran, Birgit Vogel, Karan Garg, Ajit Rao, Navneet Narula, et al. (+9) Glenn Jacobowitz, Arthur Tarricone, Vishal Kapur, Peter Faries, Michael Marin, Jagat Narula, Robert Lookstein, Jeffrey W. Olin, Prakash Krishnan |
50 |
[GO] |
2021―Mar―24 |
Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose |
Zhenzhou Wang, Zhe Du, Xiujuan Zhao, Fuzheng Guo, Tianbing Wang, Fengxue Zhu |
51 |
[GO] |
2021―Feb―11 |
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis |
Azza Sarfraz, Zouina Sarfraz, Aminah Abdul Razzack, Gaurav Patel, Muzna Sarfraz |
52 |
[GO] |
2021―Feb―10 |
Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection |
Harry N. Magnani |
53 |
[GO] |
2021―Jan―15 |
Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis |
Noppacharn Uaprasert, Chatphatai Moonla, Darintr Sosothikul, Ponlapat Rojnuckarin, Thita Chiasakul |
54 |
[GO] |
2020―Dec―29 |
Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis |
Chuanqi Cai, Yi Guo, Yun You, Ke Hu, Fei Cai, Mingxing Xie, et al. (+6) Lu Yang, Ken Ling, Dawei Ye, Sanjay Misra, Weici Wang, Yiqing Li |
55 |
[GO] |
2020―Oct―20 |
COVID-19 and Hypercoagulability: A Review |
Asim Kichloo, Kirk Dettloff, Michael Aljadah, Michael Albosta, Shakeel Jamal, Jagmeet Singh, et al. (+4) Farah Wani, Akshay Kumar, Srilakshmi Vallabhaneni, Muhammad Zia Khan |
56 |
[GO] |
2020―Oct―20 |
The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review |
Indra Wijaya, Rizky Andhika, Ian Huang |
57 |
[GO] |
2020―Oct―20 |
Prevalence and Risk Factors of Thromboembolism among Patients With Coronavirus Disease-19: A Systematic Review and Meta-Analysis |
Belayneh Kefale, Gobezie T. Tegegne, Amsalu Degu, Melaku Tadege, Desalegn Tesfa |
58 |
[GO] |
2020―Oct―15 |
Is Thrombophilic Genetic Profile Responsible for an Acute Ischemic Stroke in a COVID-19 Male Patient? |
Alexandru Burlacu, Bogdan Artene, Radu Crisan-Dabija, Iolanda Valentina Popa, Adrian Covic |
59 |
[GO] |
2020―Oct―08 |
A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients |
Xu Chen, Qinghua Wang, Min Xu, Chengbin Li |
60 |
[GO] |
2020―Sep―16 |
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review |
Nicholas Kipshidze, Patrick Iversen, Thomas R. Porter, Nodar Kipshidze, Fakiha Siddiqui, George Dangas, Jawed Fareed |
61 |
[GO] |
2020―Sep―16 |
Anticoagulation in COVID-19: DDI Perspective |
Sajad Khiali, Taher Entezari-Maleki |
62 |
[GO] |
2020―Sep―04 |
Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms |
Samuel A Berkman, Victor F Tapson |
63 |
[GO] |
2020―Sep―02 |
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic |
Faisal Alsayegh, Shaker A. Mousa |
64 |
[GO] |
2020―Aug―28 |
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients |
Yuan Yu, Jie Tu, Bingxin Lei, Huaqing Shu, Xiaojing Zou, Ruiting Li, et al. (+3) Chaolin Huang, Yali Qu, You Shang |
65 |
[GO] |
2020―Aug―26 |
COVID-19, Antiphospholipid Syndrome and Thrombosis |
Sora Yasri, Viroj Wiwanitkit |
66 |
[GO] |
2020―Aug―26 |
Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events? |
Alexandru Burlacu, Simonetta Genovesi, Iolanda Valentina Popa, Radu Crisan-Dabija |
67 |
[GO] |
2020―Aug―21 |
Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic |
Kaveh Rezaei Bookani, Iva Minga, Manisha Chander, Ksenia Hankewych, Matthew Plassmeier, Alfonso Tafur |
68 |
[GO] |
2020―Aug―14 |
COVID-19 Associated Coagulopathy and Thrombotic Complications |
Zoubida Tazi Mezalek, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, Hicham Harmouche, et al. (+2) Mouna Maamar, Mohamed Adnaoui |
69 |
[GO] |
2020―Jul―31 |
COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response |
Apoorva Jayarangaiah, Pramod Theetha Kariyanna, Xiaoyi Chen, Amog Jayarangaiah, Abhishek Kumar |
70 |
[GO] |
2020―Jul―31 |
Coronavirus Disease and Acute Vascular Events |
Gundu H. R. Rao |
71 |
[GO] |
2020―Jul―29 |
Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan |
Jianpu Chen, Xiang Wang, Shutong Zhang, Bin Lin, Xiaoqing Wu, Yanfang Wang, et al. (+4) Xiaoqi Wang, Ming Yang, Jianqing Sun, Yuanliang Xie |
72 |
[GO] |
2020―Jul―29 |
Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications |
MA Haimei |
73 |
[GO] |
2020―Jul―24 |
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19 |
Galit H. Frydman, Edward W. Boyer, Rosalynn M. Nazarian, Elizabeth M. Van Cott, Gregory Piazza |
74 |
[GO] |
2020―Jul―22 |
Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19? |
José A. Páramo |
75 |
[GO] |
2020―Jul―20 |
Viral Coagulopathy in Patients With COVID-19: Treatment and Care |
Nickolas Kipshidze, George Dangas, Christopher J. White, Nodar Kipshidze, Fakiha Siddiqui, Christopher R. Lattimer, et al. (+2) Charles A. Carter, Jawed Fareed |
76 |
[GO] |
2020―Jul―17 |
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation |
Wolfgang Miesbach, Michael Makris |
77 |
[GO] |
2020―Jul―13 |
Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium? |
Nil Guler, Fakiha Siddiqui, Jawed Fareed |
78 |
[GO] |
2020―Jul―10 |
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020 |
Eduardo Ramacciotti, Ariane Scarlatelli Macedo, Rodrigo Bruno Biagioni, Roberto Augusto Caffaro, Renato Delascio Lopes, João Carlos Guerra, et al. (+8) Fernanda Andrade Orsi, Marcos Areas Marques, Alfonso J. Tafur, Joseph A. Caprini, Andrew Nicolaides, Charles A. Carter, Cyrillo Carvalheiro Filho, Jawed Fareed |
79 |
[GO] |
2020―Jul―10 |
Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription |
Ufuk Demirci, Hande Ozdemir, Derya Demirbag-Kabayel, Elif G. Umit, Ahmet Muzaffer Demir |
80 |
[GO] |
2020―Jul―03 |
COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets |
Erkan Cure, Medine Cumhur Cure |
81 |
[GO] |
2020―Apr―06 |
Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |
Beuy Joob, Viroj Wiwanitkit |